Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIMMUNE in Friedreich's Ataxia
NCT02415127Phase 3Completed
- Sponsor
- Amgen
- Start
- Jun 2015
- Primary completion
- Nov 2016
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon gamma-1b in Friedreich's ataxia (FA), sponsored by Amgen. Started Jun 2015; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
Friedreich's ataxia (FA)
Beyond the preview
Go deeper on NCT02415127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02415127.